Image For Activity Cover
ESAP 2022
Course Description
The Endocrine Self-Assessment Program (ESAP™) is a self-study curriculum aimed at physicians seeking initial certification or recertification in endocrinology, program directors interested in a testing and training instrument, and clinicians simply wanting a self-assessment and a broad review of endocrinology. ESAP 2022 consists of 120 brand-new multiple-choice questions in all areas of endocrinology, diabetes, and metabolism. There is extensive discussion of each answer option, with references. ESAP is updated annually with new questions. For accessibility for international practitioners, SI units are included.

Learning Options
Assess your clinical knowledge through different learning modes:
  • ESAP 2022 Learning Mode: This is the "traditional" ESAP. Answer 120 questions and receive immediate feedback and view the detail answer rationale. This mode must be completed with a passing score of 70% in order to earn CME and MOC.
  • Mock Exam Mode: Perfect for simulating an exam. Retake this mock exam as often as you like and each time the questions will be re-organized. Feedback will be provided after completion of the exam.
    • Topical Learning Mode: Within Mock Exam Mode, you have the option to create your own exams by choosing the topic(s) to be included


METHOD OF PARTICIPATION
This enduring material is presented online and in print format. The estimated time to complete this activity, including review of material, is 40 hours. Participants must achieve a minimum score of 70% to claim CME credit and MOC points. After initially completing the module(s), if participants do not achieve a minimum score of 70%, they have the option to change their answers and make additional attempts to achieve a passing score. Participants also have the option to clear all answers and start over. Credit is only available on the standard ESAP learning mode.

LAST REVIEW DATE: December 2021

ACTIVITY RELEASE DATE: February 2022

ACTIVITY EXPIRATION DATE: December 31, 2024 (date after which this enduring material is no longer certified for AMA PRA Category 1 Credits and ABIM Medical Knowledge MOC points)

Target Audience
ESAP is a self-study curriculum aimed at physicians seeking initial certification or recertification in endocrinology, program directors interested in a testing and training instrument, and clinicians wanting a self-assessment and a broad review of endocrinology.
Learning Objectives

Upon completion of this educational activity, participants will be able to:

  • Recognize clinical manifestations of endocrine and metabolic disorders and select among current options for diagnosis, management, and therapy.
  • Identify risk factors for endocrine and metabolic disorders and develop strategies for prevention.
  • Evaluate endocrine and metabolic manifestations of systemic disorders.
  • Use existing resources pertaining to clinical guidelines and treatment recommendations for endocrine and related metabolic disorders to guide diagnosis and treatment.
Accreditation Statement

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 40.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.


Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC) - if eligible
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 40.00 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME, please contact the Endocrine Society at info@endocrine.org.

Faculty and Disclosures

Lisa R. Tannock, MD, Program Chair
Professor of Medicine
University of Kentucky and
Department of Veterans Affairs

Barbara Gisella Carranza Leon, MD
Assistant Professor of Medicine
Division of Diabetes, Endocrinology,
and Metabolism
Vanderbilt University Medical Center

Alice Y. Chang, MD, MSc
Assistant Professor
Division of Endocrinology,
Diabetes, and Nutrition
Mayo Clinic

Dima Lutfi Diab, MD
Associate Professor of Clinical Medicine
University of Cincinnati

Nicole M. Ehrhardt, MD
Assistant Professor of Medicine
University of Washington Diabetes Institute

Nazanene H. Esfandiari, MD
Associate Professor
University of Michigan

Mathis Grossmann, MD, PhD, FRACP
Professor of Medicine
University of Melbourne
Austin Health

Mark Gurnell, MBBS, MA
(Med Ed), PhD, FRCP
Professor of Clinical Endocrinology
& Clinical SubDean
University of Cambridge,
Wellcome Trust-MRC Institute
of Metabolic Science &
School of Clinical Medicine

Sarah E. Mayson, MD
Associate Professor of Medicine

Director of the Endocrinology Fellowship Program

Division of Endocrinology, Metabolism, and Diabetes

University of Colorado School of Medicine


Kevin M. Pantalone, DO, FACE
Staff Endocrinologist
Director of Diabetes Initiatives
Department of Endocrinology
Cleveland Clinic

Deepika Reddy, MD
Assistant Professor
Division of Diabetes, Endocrinology,
and Metabolism
University of Utah Healthcare

Roberto Salvatori, MD
Professor of Medicine
Medical Director,
Johns Hopkins Pituitary Center
Johns Hopkins University

Meera Shah, MB ChB, MRCP
Assistant Professor of Medicine,
Mayo Clinic College of Medicine
Consultant, Division of Endocrinology,
Mayo Clinic – Rochester

Aniket Sidhaye, MD
Assistant Professor of Medicine
Johns Hopkins University

Anand Vaidya, MD, MMSC
Associate Professor of Medicine
Brigham and Women’s Hospital
Harvard Medical School

Thomas J. Weber, MD
Associate Professor of Medicine
Division of Endocrinology,
Metabolism, and Nutrition
Duke University Medical Center

Abbie L. Young, MS, CGC, ELS(D)
Medical Editor

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s ESAP Faculty Working Group.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The following faculty reported relevant financial relationship(s): Roberto Salvatori, MD, receives grant funds from Roche, NIH, and the Department of Defense. He is on the advisory board of NovoNordisk, Ipsen, and Strongbridge Biopharma. He serves as a clinical trial investigator for Corcept Therapeutics, Chiasma (now Amryt), and Crinetics Pharmaceuticals. Anand Vaidya, MD, MMSC, is a consultant for Mineralys, HRA Pharma, and Corcept. Thomas J. Weber, MD, is a consultant for Ultragenyx Pharmaceutical, Pharmacosmos, and Lakeside Life Science. He is also a primary investigator for Ultragenyx Pharmaceutical. His spouse is a primary investigator for AstraZeneca, Sanofi, and Robling Pharmaceutical. Kevin M. Pantalone, DO, is a consultant for AstraZeneca, Bayer, Corcept, Diasome, Eli Lilly, Merck, Novo Nordisk, and Sanofi. He is a speaker for AstraZeneca, Corcept, Merck, and Novo Nordisk. He also receives research support from Bayer, Merck, and Novo Nordisk. Barbara Gisella Carranza Leon, MD, is a coinvestigator for clinical trials and/or research studies for Novartis, IONIS Pharmaceutical Inc, NIH, FH Foundation, and Regenxbio, Inc. Meera Shah, MB ChB, MRCP, is a research collaborator for Pendulum Therapeutics, Inc. The compensation is paid to Mayo Clinic in lieu of her time. Nicole M. Ehrhardt, MD, is a consultant for Novo Nordisk and Dexcom. She is the recipient of educational grants from Novo Nordisk and Merck and the recipient of an investigator-initiated grant from Dexcom. Mathis Grossmann, MD, PhD, FRCP, receives research support for investigator-initiated studies from Bayer AG and Otsuka, and speaker honoraria from Bayer AG, Besins Health Care, and Novartis.

The following committee members reported no relevant financial relationships: Lisa R. Tannock, MD; Alice Y. Chang, MD, MSc; Dima Lutfi Diab, MD; Nazanene H. Esfandiari, MD; Mark Gurnell, MBBS, MA (Med Ed), PhD; Deepika Reddy, MD; Aniket Sidhaye, MD; Sarah E. Mayson, MD

The medical editor for this program, Abbie L. Young, MS, CGC, ELS(D), reported no relevant financial relationships.

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This activity is not supported by educational grant(s) or other funds from any commercial supporter.

Summary
Availability: On-Demand
Expires on Dec 31, 2024
Cost: Member: $250.00
Non-Member: $350.00
In-Training Member: $199.00
Resident Member: $0.00
Resident Non-Member: $0.00
Credit Offered:
40 AMA PRA Category 1 Credits
40 ABIM-MOC Points
40 Participation Credits
Contains: 2 Courses
Recommended
   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By